Oncobeta ® GmbH - epidermal radioisotope therapy




OncoBeta® GmbH, located at the Garching Technology and Founders Center GATE near Munich, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative therapies utilizing epidermal radioisotope applications.
OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers.
Future oriented, we seek, develop and deliver therapies which provide painless, customized, single-session applications that achieve exceptional cosmetic results.

www.oncobeta.com